# New York Blood Center Enterprises – FDA Inspection, Dec 9, 2010

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/73d3b19a-f6af-417a-9635-3628a0da597c
Source feed: FDA_Inspections

> FDA inspection 700863 of New York Blood Center Enterprises, December 09, 2010. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 700863
- Company Name: New York Blood Center Enterprises
- Inspection Date: 2010-12-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1302348 - 2026-02-11](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/773424e8-c0f3-4a89-b4fc-f157c4b9e3a8)
- FDA Inspection 1132998 - 2020-11-05
- FDA Inspection 1040884 - 2018-02-07
- FDA Inspection 952436 - 2015-12-02
- FDA Inspection 892079 - 2014-08-20

Company: https://www.keypedia.com/companies/new-york-blood-center-enterprises/64d20e9b-de77-469c-8cde-1ed160bda83d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
